Quadcap Wealth Management, LLC Crispr Therapeutics Ag Transaction History
Quadcap Wealth Management, LLC
- $440 Billion
- Q1 2024
A detailed history of Quadcap Wealth Management, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Quadcap Wealth Management, LLC holds 7,299 shares of CRSP stock, worth $411,736. This represents 0.11% of its overall portfolio holdings.
Number of Shares
7,299
Previous 9,386
22.24%
Holding current value
$411,736
Previous $588 Million
15.33%
% of portfolio
0.11%
Previous 0.15%
Shares
2 transactions
Others Institutions Holding CRSP
# of Institutions
541Shares Held
55.8MCall Options Held
2.91MPut Options Held
2.47M-
Capital International Investors Los Angeles, CA7.84MShares$442 Million0.11% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.78MShares$439 Million3.82% of portfolio
-
Nikko Asset Management Americas, Inc.3.27MShares$184 Million2.23% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.3.15MShares$178 Million0.13% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.7MShares$153 Million0.11% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $4.4B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....